Singapore, March 13 -- At the APAC Biomanufacturing Leadership Summit 2026 in Singapore, organised by Charles River, BioSpectrum Asia spoke with Heath Coats, MS, Senior Principal and Head of Quality and Compliance at Dark Horse Consulting, and former FDA DMPQ official. With extensive experience in regulatory oversight and quality systems, Coats offers a perspective on how quality culture, procedural alignment, and regulatory preparedness will shape the next phase of advanced biomanufacturing. In this conversation, he discusses opportunities for improving compliance practices in APAC, the evolving regulatory pathways for cell and gene therapies, and the importance of leveraging established biologics manufacturing expertise to support emerg...